These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23887827)

  • 1. Choice of insurer for basic health insurance restricted by supplementary insurance.
    Duijmelinck DM; van de Ven WP
    Eur J Health Econ; 2014 Sep; 15(7):737-46. PubMed ID: 23887827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands.
    Willemse-Duijmelinck DMID; van de Ven WPMM; Mosca I
    Health Policy; 2017 Oct; 121(10):1085-1092. PubMed ID: 28855064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
    Duijmelinck DM; Mosca I; van de Ven WP
    Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dutch health insurance reform: switching between insurers, a comparison between the general population and the chronically ill and disabled.
    de Jong JD; van den Brink-Muinen A; Groenewegen PP
    BMC Health Serv Res; 2008 Mar; 8():58. PubMed ID: 18366678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching rates in health insurance markets decrease with age: empirical evidence and policy implications from the Netherlands.
    Duijmelinck DM; van de Ven WP
    Health Econ Policy Law; 2016 Apr; 11(2):141-59. PubMed ID: 26173559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of supplementary health insurance on switching behaviour: evidence from Swiss data.
    Dormont B; Geoffard PY; Lamiraud K
    Health Econ; 2009 Nov; 18(11):1339-56. PubMed ID: 19267356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intention to switch health insurer and actual switching behaviour: are there differences between groups of people?
    Hendriks M; de Jong JD; van den Brink-Muinen A; Groenewegen PP
    Health Expect; 2010 Jun; 13(2):195-207. PubMed ID: 19906212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can Europe learn from the managed care backlash in the United States?
    Duijmelinck D; van de Ven W
    Health Policy; 2016 May; 120(5):509-18. PubMed ID: 27055353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the chronically ill population in the Netherlands switch their health insurer as often as the general population? Empirical evidence from a nationwide survey study.
    van der Schors W; Brabers AEM; De Jong JD
    BMC Health Serv Res; 2020 May; 20(1):376. PubMed ID: 32370798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptance of selective contracting: the role of trust in the health insurer.
    Bes RE; Wendel S; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2013 Oct; 13():375. PubMed ID: 24083663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consumer choice of social health insurance in managed competition.
    Kerssens JJ; Groenewegen PP
    Health Expect; 2003 Dec; 6(4):312-22. PubMed ID: 15040793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The key role of health insurance in a cost-effective health care system. Towards regulated competition in the Dutch medical market.
    van de Ven WP
    Health Policy; 1987 Apr; 7(2):253-72. PubMed ID: 10312077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do people not switch insurer in a market-based health insurance market? Empirical evidence from the Netherlands.
    van der Schors W; Brabers AEM; de Jong JD
    Eur J Public Health; 2020 Aug; 30(4):633-638. PubMed ID: 32236545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does supplementary health insurance play a role in the switching behaviour of citizens in the Netherlands?
    Holst L; Brabers A; de Jong J
    J Mark Access Health Policy; 2022; 10(1):2015863. PubMed ID: 34925712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How is enrollees' trust in health insurers associated with choosing health insurance?
    van der Hulst FJP; Brabers AEM; de Jong JD
    PLoS One; 2023; 18(11):e0292964. PubMed ID: 37917768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spillover effects of supplementary on basic health insurance: evidence from The Netherlands.
    Roos AF; Schut FT
    Eur J Health Econ; 2012 Feb; 13(1):51-62. PubMed ID: 20862510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What health plans do people prefer? The trade-off between premium and provider choice.
    Determann D; Lambooij MS; de Bekker-Grob EW; Hayen AP; Varkevisser M; Schut FT; Wit GA
    Soc Sci Med; 2016 Sep; 165():10-18. PubMed ID: 27485728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of the Dutch experience with health insurers acting as healthcare advisors.
    Victoor A; Brabers AEM; van Esch TEM; de Jong JD
    PLoS One; 2019; 14(11):e0224829. PubMed ID: 31703085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To what degree do patients actively choose their healthcare provider at the point of referral by their GP? A video observation study.
    Potappel AJC; Meijers MC; Kloek C; Victoor A; Noordman J; Olde Hartman T; van Dulmen S; de Jong JD
    BMC Fam Pract; 2019 Dec; 20(1):166. PubMed ID: 31787107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementary health insurance as a tool for risk-selection in mandatory basic health insurance markets.
    Paolucci F; Schut E; Beck K; Gress S; Van de Voorde C; Zmora I
    Health Econ Policy Law; 2007 Apr; 2(Pt 2):173-92. PubMed ID: 18634661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.